General Practice Doctors in South Pasadena, FL Accepting Medicare

3 General Practice doctors found. Showing 1 - 3

Fritz Daniel Brink, D.O. General Practice Medicare: Medicare Enrolled Practice Location: 1609 Pasadena Ave S Ste 3m, South Pasadena, FL 33707 Phone: 586-576-4140    Fax: 586-576-4146

Dr. Bernardo Francisco Malaga, MD General Practice Medicare: May Accept Medicare Assignments Practice Location: 1615 Pasadena Ave S Ste 350, South Pasadena, FL 33707 Phone: 727-345-6337

Maria Planthara Chatham, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 7400 Sun Island Dr S Apt 501, South Pasadena, FL 33707 Phone: 727-543-7797

News Archive

Low birth weight linked to poor growth in children with CKD

The lower the birth weight, the greater the chance of poor growth rate in children with chronic kidney disease (CKD), according to a new study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN).

SARS-CoV-2 containment and elimination strategy will require long-term population-wide prevention measures

By introducing a model that reveals long SARS-CoV-2 transmission chains and inadequate passive surveillance systems, a new medRxiv* preprint paper shows that bringing the infection completely under control will have to rely on presumptive, stringent, longer and more burdensome population-wide prevention measures already employed against community transmission.

You can see friends and relatives during the pandemic surge — but do it careful

Cooped up too long, yearning for a day at the beach or a night on the town — and enticed by the easing of restrictions just as the warm weather arrived — many people have bolted from the confines of home. And who can blame them?

AtheroNova completes active treatment portion of Phase 1 clinical trial with AHRO-001

AtheroNova Inc., a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announces achievement of a major milestone with the completion of the active treatment portion of its Phase 1 clinical trial with its lead compound, AHRO-001. The Phase 1 study objective is to evaluate the safety, tolerability and pharmacokinetics of AHRO-001 in healthy volunteers. The clinical study is being conducted in Russia with AtheroNova's licensing partner, OOO CardioNova.

Rebuilder Medical Technologies is in concluding stages of finalizing a national contract to provide billing services for all physicians

ReBuilder Medical Technologies, Inc. (Pink Sheets: RBRM) a provider of electronic treatments for the pain resulting from peripheral neuropathy and Peripheral Artery Disease today announced that it is in the final stages of negotiating a national contract to provide all physicians with billing services for Medicare claims for the ReBuilder.

Read more Medical News

› Verified 7 days ago